|
B.C.-Led PROOF Centre for Excellence Partners With Pfizer Canada in Fight Against Vital Organ Failure Researchers focus on the identification of biomarkers to predict and accelerate diagnosis of heart, lung and kidney failure Mon., Feb. 16, 2009 VANCOUVER, BRITISH COLUMBIA - Pfizer Canada and the PROOF (PRevention Of Organ Failure) Centre of Excellence for Commercialization and Research announced today they are teaming up in the fight against vital organ failure (heart, lung and kidney). In Canada, the personal, societal and economic consequences of this type of organ failure cost our health care system more than $35 billion a year. This serious health issue is fueled by the parallel epidemics of obesity, diabetes, and smoking-related conditions. Read more Pfizer Increases Financial Support for BC-Based Innovation Through the Centre for Drug Research and Development VANCOUVER - Pfizer Canada has increased its initial commitment of $1 million by an additional $2 million to the "Pfizer-CDRD Innovation Fund" at the Centre for Drug Research and Development (CDRD) to fast-track the commercialization of some of B.C.'s most promising research. The Innovation Fund, now totaling $3 million, is already supporting six unique scientific opportunities with promising commercialization potential in the area of cancer and diabetic ulcer healing. Read more The European Life Sciences Journal No. 4 - Winter 2008 Saving our forests Genomics-based forestry research is branching out, quite literally, as international collaborations find innovative ways to help sustain one of the world’s most precious natural resources. FORESTRY With rapid urbanisation, rising global temperatures, and the spread of epidemics, such as the mountain pine beetle in British Columbia, countries are turning to scientific research to help find ways to sustain their valuable forests. But where and how does this research occur? Enter Dr. Joerg Bohlmann. The University of British Columbia (UBC) professor is one of five lead investigators spearheading a trio of innovative genomics-based forestry research projects, with a combined value of nearly CAD 35 million. To read more, go to page 3 of 9 in the Canada section of the magazine. BioMarine 2008 Webcast View footage of the 2008 BioMarine conference in Toulon and Marseille France held in October at www.video.marinebiztv.com Program keeps bright lights at home 'Canada is falling behind in the knowledge economy,' says research network chief By Marke Andrews, Vancouver Sun January 12, 2009 It's an all-too-common story. An accomplished Canadian university student who's good with numbers cannot find work and has to leave the country to do research and development elsewhere. Kirk Hutton is bucking that trend.... read more Universities are strategic partners for economic recovery By Stephen Toope, Michael Stevenson, David Turpin and Charles Jago, Special to the Sun January 15, 2009 The world is facing an unprecedented economic crisis. Canada and British Columbia are not immune and while it is expected that B.C. will be less severely affected than other jurisdictions, we must take strategic actions over the next few months. Now, more than ever, it is critical that we maintain our focus on the elements of success for B.C.'s economy of the future... read more B.C.-federal fund to fuel knowledge jobs Canwest News Service January 20, 2009 B.C. and the federal government are teaming up to bolster the economy through a $50-million partnership. It is the first of four agreements being announced in Western Canada this week, Lynne Yelich, minister of state for Western Economic Diversification, said Monday in Vancouver.... read more B.C. genetics researchers work to predict drug reactions in children Friday, January 23, 2009 CBC News A new research project in British Columbia aims to develop a tool to allow drug doses for children to be tailored to their individual genetic makeup in order to help prevent potentially life-threatening drug reactions. According to Health Canada, more than half of newly approved therapeutic health products prompt serious reactions that are discovered only after the product reaches the market. Three-quarters of medications have never been tested in children... read more 25 B.C. companies escape recession's gravity to make this year's Ready to Rocket list By Gillian Shaw, Vancouver Sun January 28, 2009 If there's a recession on, it's news to 25 British Columbia companies that have been named to this year's Ready to Rocket list... read more Breast Cancer Survival Predicted by New Canadian Tool February 2, 2009 Jordana Huber, Canwest News Service TORONTO -- Researchers in Toronto have developed a new tool that will enable doctors to better predict whether a patient with breast cancer will survive their disease. The new technology analyzes breast cancer tumours to determine a patient's best treatment options and can predict with more than 80 per cent accuracy a patient's chance of recovering from breast cancer, according to a study published this week in Nature Biotechnology online. Read more Recession short-circuiting alternative fuel initiatives But promising green signals from U.S. government are helping reassure B.C.’s rattled renewable energy sector Business in Vancouver February 24-March 2, 2009; issue 1009 Krisendra Bisetty The global economic slump has taken the sheen out of clean. Renewable energy companies have been left wondering if they’re still relevant in a recession and with oil at US$40 a barrel. For some industry players, including wood waste-to-ethanol developer Lignol Energy Corp. (TSX-V:LEC), high hopes of breaking into the U.S. and Canadian energy markets have come crashing down... read more |
 Suite 900 - 1188 West Georgia St.
Vancouver, BC V6E 4A2 |